EZH2 and lung carcinoma: In lung cancer, CCL2 expression was attenuated by EZH2-mediated H3K27me3 in the enhancer regions and DNMT1-mediated DNA methylation in the promoter regions [178], impeding M2-like phenotype of macrophages thereby facilitating metastasis and infiltration [179].